Latest filing published 25 Nov 2022 for VALEO PHARMA INC., €9,544.
Jeffrey Michael Skinner appears in our data through filings on Valeo Pharma Inc. shares, published by SEDI. In total, 14 filings cover trades dated from 17 December 2019 to 25 November 2022.
Both buying and selling appear: 6 purchases worth €73k, against 4 sales worth €91k. Taken together, the sales exceed the purchases by €18k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 option exercises.
In size, the median ticket on the buying side is €10k. Across 6 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 25 November 2022 with an option exercise (€9,544) in Valeo Pharma Inc. The clock since the last published purchase (27 September 2021) now reads 1,857 days. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations